Sign up to save your podcasts
Or
Share S03E99 - Joseph Tucker - Drugs for Neuroplasticity
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
S03E99 - Joseph Tucker - Drugs for Neuroplasticity
In this episode of The Mindfulness Experience Podcast, host Keith Fiveson interviews Dr. Joseph Tucker, the CEO and Director of Enveric Biosciences. Enveric Biosciences is a biotechnology company that is dedicated to developing small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Dr. Tucker has an impressive background in building several publicly traded biotechnology companies and works tirelessly to provide innovative solutions for mental health disorders.
During the interview, Dr. Tucker talks about Enveric Biosciences' lead program, the EVM201 Series, and how it offers a new approach to treating psychiatric disorders. He discusses the challenges of traditional methods and how his company uses psilocybin and neuroplasticity to develop safe and effective treatment options. He also provides insights into upcoming programs and developments in the pipeline that will contribute to the future of mental health therapeutics. This informative and insightful episode offers hope for those suffering from mental health disorders and provides an in-depth look into the innovative solutions being developed by Enveric Biosciences. For more information, go to: https://www.enveric.com/
🔥 EXCLUSIVE DISCOUNT FOR OUR LISTENERS! 🔥
Don't let this incredible opportunity pass you by!
Sign up now at wonderlandconference.com using our special discount code MINDFULNESS20 to receive a 20% reduction on your tickets.
Alternatively, you can use this unique link for an automatic 20% OFF: https://wonderlandconference.com/tickets/?coupon=MINDFULNESS20
See you in Miami!
View all episodes
By Keith W FivesonIn this episode of The Mindfulness Experience Podcast, host Keith Fiveson interviews Dr. Joseph Tucker, the CEO and Director of Enveric Biosciences. Enveric Biosciences is a biotechnology company that is dedicated to developing small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Dr. Tucker has an impressive background in building several publicly traded biotechnology companies and works tirelessly to provide innovative solutions for mental health disorders.
During the interview, Dr. Tucker talks about Enveric Biosciences' lead program, the EVM201 Series, and how it offers a new approach to treating psychiatric disorders. He discusses the challenges of traditional methods and how his company uses psilocybin and neuroplasticity to develop safe and effective treatment options. He also provides insights into upcoming programs and developments in the pipeline that will contribute to the future of mental health therapeutics. This informative and insightful episode offers hope for those suffering from mental health disorders and provides an in-depth look into the innovative solutions being developed by Enveric Biosciences. For more information, go to: https://www.enveric.com/
🔥 EXCLUSIVE DISCOUNT FOR OUR LISTENERS! 🔥
Don't let this incredible opportunity pass you by!
Sign up now at wonderlandconference.com using our special discount code MINDFULNESS20 to receive a 20% reduction on your tickets.
Alternatively, you can use this unique link for an automatic 20% OFF: https://wonderlandconference.com/tickets/?coupon=MINDFULNESS20
See you in Miami!